Accelerating the lab to market transition of AI tools for cancer management

CHAIMELEON

Duration

4 years

Website

https://chaimeleon.eu/

Partners

18 partners

Budget

€9 million

The process

Description

CHAIMELEON is a project aimed at establishing an EU-wide repository for health imaging data to enhance AI-driven cancer management research. This repository will adhere to the legal and ethical standards of the involved countries and build on existing data infrastructures such as the PRIMAGE repository for pediatric cancer, the Euro-BioImaging node, the Radiomics Imaging Archive by Maastricht University, DRIM AI France, and the Oncology imaging biobank by Pisa University. The repository will gather multimodality imaging and associated clinical data for lung, prostate, colon, and rectal cancers from both historical and newly diagnosed patients. An analytical engine will facilitate the extraction and interpretation of this data, supporting AI pipelines that automate data de-identification, curation, annotation, and harmonization—critical for ensuring reproducibility across large, diverse datasets. The repository’s effectiveness as a tool for AI experimentation will be validated through open challenges to the AI community and in-silico validation in observational studies across European hospitals, focusing on key clinical decisions related to major cancer types.

MATICAL’s role

Coordination of the proposal preparation.
Part of the Project Management Office. Leader of the Sustainability and Exploitation Work Package

Programme / Type

Horizon 2020 / RIA

Area

Healthcare, Cancer diagnosis and treatment, Federated Data, AI, Big Data, European Health Data Space

The process

Description

MATICAL’s role

Coordination of the proposal preparation.
Part of the Project Management Office. Leader of the Sustainability and Exploitation Work Package

Programme / Type

Horizon 2020 / RIA

Area

Healthcare, Cancer diagnosis and treatment, Federated Data, AI, Big Data, European Health Data Space

Let's innovate with purpose!

In embracing these core principles, we ensure our contributions to the health sector are meaningful, impactful, and consistent with our mission. We invite you to partner with us, to create a healthier, brighter future together.

Partners & Collaborative Networks

We are the strategic partners of choice for leading EU biotech enterprises and technology transfer offices. With us, they assess their innovations’ impact, formulate robust go-to-market strategies, and analyze cost-benefits for novel medical devices and associated technologies. Our expansive network encompasses the most influential figures in the EU health sector, from cutting-edge biotech firms, where health data is paramount, to AI-driven solutions targeting cancer and rare diseases.